Iohexol Zentiva

Iohexol, the active ingredient in Iohexol Zentiva, is a non‑ionic iodinated contrast agent presented as a sterile solution for intraarterial, intrathecal, intravenous use. It provides radiographic contrast that enhances visualization of vascular and tissue structures during diagnostic imaging procedures.

GNH USA supplies Iohexol Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iohexol Zentiva is used as a contrast medium in several radiologic examinations, improving image quality by increasing X‑ray attenuation.

- Angiography: enhances visualization of blood vessels and vascular anomalies. - Computed Tomography (CT) scanning: improves differentiation of soft‑tissue structures and lesions. - Myelography: provides clear contrast within the spinal canal for nerve root assessment. - Urography: delineates the urinary tract and renal collecting system.

Adverse reactions to Iohexol Zentiva can range from mild to severe and are reported in clinical practice.

Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or vomiting. - Headache. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Allergic reactions, including anaphylaxis. - Seizures or neurological disturbances. - Acute renal impairment, especially in patients with pre‑existing kidney disease.

When using Iohexol Zentiva, clinicians should observe several safety measures.

- Assess renal function: evaluate serum creatinine and eGFR before administration. - Check for iodine or contrast media allergy: obtain a thorough allergy history. - Ensure adequate hydration: promote renal clearance of the agent. - Avoid in patients with severe hyperthyroidism: iodine load may exacerbate the condition. - Store at ambient temperature: keep in original container, protect from light and moisture.

Iohexol Zentiva may interact with other drugs, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: increases total iodine load. - High‑dose iodinated medications (e.g., amiodarone): may potentiate thyroid effects. - Nephrotoxic agents such as aminoglycosides: heighten risk of renal injury.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance. - Metformin: risk of lactic acidosis if renal function declines. - ACE inhibitors or ARBs: monitor blood pressure and renal parameters.